Author

Meike Vogler

Goethe University FrankfurtORCID 0000-0003-2650-586XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrea G. S. PepperiD· 1 shared Andrea SinziD· 1 shared Chris J. PepperiD· 1 shared Christian H. IhlingiD· 1 shared Dirk HeckliD· 1 shared Hasan IssaiD· 1 shared Ielyaas CloeteiD· 1 shared Jan‐Henning KlusmanniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Andrea G. S. PepperORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 11, 2025

Activation of the TP53 pathway is a therapeutic vulnerability in NUP98::KDM5A+ pediatric AML

L. Cifarelli, Hasan Issa, Ludovica Proietti…·Dirk Heckl

This study identifies TRIP13 as a developmentally restricted dependency in NUP98::KDM5A+ pediatric AML, showing that its inhibition reactivates TP53 and kills leukemic cells.

1 citation

humanproteomics

𝕏 PostBluesky

Systems Biologynpj Systems Biology and ApplicationsPeer-reviewedJun 6, 2023

Computational modeling of DLBCL predicts response to BH3-mimetics.

Ielyaas Cloete, Victoria M. Smith, Ross A. Jackson…·Simon A. Mitchell

This study uses computational systems biology to predict DLBCL cell response to BH3-mimetics by modeling molecular variability and genetic lesions.

7 citations

humanstatistical model

𝕏 PostBluesky